Pillstats
Rx only · Injection, Suspension · Ophthalmic

Triamcinolone Acetonide

Brands: Triesence · Xipere · Triamcinolone Acetonide

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA01AC01
RxCUI (US)10759
US makers3 labelers
Packages4
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3567111.1K1.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.2K
Rx · 2026 Q1
1.1K
Units dispensed
+447%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bausch & Lomb Incorporatedunknown2SUPPLYING
Harrow Eye, LLCunknown1SUPPLYING
Novartis Pharmaceuticals Corporationunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 27, 2021
    SHORTAGEDrug shortage: Triamcinolone Acetonide Injection (Harrow Eye, LLC)

    Triamcinolone Acetonide Injection — reported in shortage by Harrow Eye, LLC. Therapeutic category: Ophthalmology.